Related Experiment Video
Updated: Dec 11, 2025

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Ocular Complications of Intravesicular BCG Treatment for Bladder Carcinoma
Osman Melih Ceylan1, Ali Hakan Durukan1, Yusuf Uysal1
1Department of Ophthalmology, University of Health Science, Gulhane School of Medicine, Ankara, Turkey.
Purpose:
To report genital and ocular Bacillus Calmette-Guérin (BCG) infection as a rare complication of intravesical BCG immunotherapy.
Methods:
We report a patient with bladder carcinoma who developed penile and ocular BCG infection. Medical history, clinical features, imaging findings, histopathological evaluation, and response to treatment clinched the diagnosis.
Result:
Granulomatous inflammation was noted on histopathological evaluation of lung and cutaneous lesion of the penis. The left eye with choroidal tubercle and tractional retinal detachment involving fovea underwent pars plana vitrectomy. After silicone removal, best-corrected visual acuity was 20/100 and patient received anti-TB regimen for 12 months. At 1 year follow-up, the choroidal tuberculoma was found to have completely resolved and the ocular status was stable.
Conclusions:
Though there are other reported cases of BCG infection secondary to intravesical BCG instillation noted in the literature, penile granuloma accompanying with choroidal tubercle is an uncommon form among these complications.
Related Concept Videos
Angle Closure Glaucoma: Treatment
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Urinary Tract Calculi VI: Surgical Management
Urinary Tract Calculi III: Medical Management
Imaging Studies VI: Voiding Cystourethrography and Cystography

